INSIGHTS ON CLINICAL TRIAL DESIGN

• Expanding Clinical Research In East Africa With Digital Innovation

  Africa carries 25% of the world’s disease burden but hosts only 1% of clinical trials. Discover technology-driven strategies that close this gap and transform research access in underserved regions.

• GA Screening: Early Detection For Future Trial Recruitment

  Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.

• Elevating The Site Voice

  A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

• Diversity In Clinical Trials: LGBTQIA+ Community Needs Not Just Allies, But Crusaders

  In an ACRP webinar on LGBTQIA+ diversity in clinical trials, industry panelists came together to discuss FDA action plans, SOGI data, advocacy efforts, challenges of transgender patients, and more.

• How High-Performing Trials Operationalize Health Equity Early

  9/17/2025

  Explore how embedding inclusion early in clinical development enhances enrollment, strengthens data integrity, and improves outcomes, especially in oncology and rare disease trials.

• The Importance Of A Maturity Model For Clinical Trial Transparency

  10/23/2024

  A comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.

• Pharmacy Considerations For Early Phase Trials

  5/8/2026

  This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.

• Strategic Implications Of The Single Phase 3 Approval Paradigm

  7/21/2026

  As FDA single-trial approvals gain traction, CNS developers need stronger early evidence. Learn how biomarkers, patient selection, and regulatory strategy can accelerate development.

• Applying AI to Study Simulation: From Design to Analysis

  5/12/2026

  See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.